Beta Bionics, Inc. (BBNX) PT Raised to $25 at UBS

September 15, 2026 6:27 AM

UBS analyst Patrick Wood raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $25.00 (from $22.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found